RESIDUAL DISEASE
Clinical trials for RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a vaccine stop Triple-Negative breast cancer from coming back?
⭐️ VACCINE ⭐️ CompletedThis early-phase trial tests an experimental vaccine made from the alpha-lactalbumin protein, found in breast tissue, to see if it can safely train the immune system to fight triple-negative breast cancer cells. The study enrolls people who have completed treatment for non-metast…
Matched conditions: RESIDUAL DISEASE
Phase: EARLY_PHASE1 • Sponsor: George T. Budd • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 19, 2026 00:00 UTC
-
New combo therapy shows promise for myeloma patients with remaining disease
Disease control CompletedThis study looked at 42 people with multiple myeloma that was still present after a stem cell transplant. It compared continuing lenalidomide alone versus adding two other drugs (ixazomib and dexamethasone) to try to eliminate the remaining cancer. The goal was to see which appro…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC